Horan Securities’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-2,210
| Closed | -$7K | – | 401 |
|
|
2020
Q1 | $7K | Buy |
+2,210
| New | +$7K | 0.01% | 152 |
|
|
2019
Q4 | – | Sell |
-2,210
| Closed | -$9K | – | 237 |
|
|
2019
Q3 | $9K | Hold |
2,210
| – | – | 0.01% | 169 |
|
|
2019
Q2 | $10K | Hold |
2,210
| – | – | 0.01% | 177 |
|
|
2019
Q1 | $9K | Hold |
2,210
| – | – | 0.01% | 152 |
|
|
2018
Q4 | $8K | Hold |
2,210
| – | – | 0.01% | 153 |
|
|
2018
Q3 | $8K | Hold |
2,210
| – | – | 0.01% | 135 |
|
|
2018
Q2 | $9K | Hold |
2,210
| – | – | 0.01% | 130 |
|
|
2018
Q1 | $9K | Buy |
2,210
+960
| +77% | +$3.91K | 0.01% | 122 |
|
|
2017
Q4 | $8K | Buy |
1,250
+160
| +15% | +$1.02K | 0.01% | 128 |
|
|
2017
Q3 | $5K | Hold |
1,090
| – | – | ﹤0.01% | 152 |
|
|
2017
Q2 | $4K | Hold |
1,090
| – | – | ﹤0.01% | 151 |
|
|
2017
Q1 | $3K | Buy |
+1,090
| New | +$3K | ﹤0.01% | 161 |
|